Lucera Erick bought DYN
February 12, 2026 · Form 4 insider transaction
Lucera Erick bought 105,000 shares of Dyne Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
105,000
Price
$0.00
Total value
N/A
InsiderLucera Erick
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2026
Filing dateFebruary 17, 2026
Shares owned after105,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on February 12, 2026. The shares underlying the option are scheduled to vest over four years in equal monthly installments through February 12, 2030.